All News

The combination therapy reduced the risk of squamous cell carcinoma development on the face and scalp by approximately 75% in the study.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care industry.

With this approval, certolizumab pegol becomes the first FDA-approved therapy for this type of axSpA, filling an unmet clinical need for treatment options, according to the release.

The action follows discontinuation of quinidine, the only FDA-approved intravenous antimalarial drug in the United States.

Certolizumab pegol (Cimzia) is the first FDA-approved therapy for this type of axial spondyloarthritis, filling an unmet clinical need for treatment options.

Aspirin and heroin were discovered within weeks of each other in 1897 by Felix Hoffmann.

ASHP’s Midyear Clinical Meeting rose 5 spots, from No. 157 to No. 152 out of 250 trade shows with the Consumer Electronics Shows (CES) topping the list.

Overall, more than half of commercially insured individuals who initiated pre-exposure prophylaxis persisted with it for the 12-month duration of the cohort study.

Top news of the day from across the health care industry.

According to the study, enzyme USP15 may regulate cancer cell response to poly-(ADP-ribose) polymerase inhibitors.

An increasing number of patients with decompensated cirrhosis are receiving direct-acting antiviral treatment and attaining sustained virologic response of hepatitis C, however, their long-term outcomes are unclear.

Officials with the FDA approved Wednesday testosterone undecanoate (Jatenzo, Clarus Therapeutics), an oral testosterone capsule for treating men with certain forms of hypogonadism.

The drug is indicated to for men with low testosterone levels due to specific medical conditions, such as genetic disorders, including Klinefelter syndrome or tumors that have damaged the pituitary gland.

The acquisition of Wellcare Health Plans will create a centralized health care enterprise focused on government-sponsored health care programs on the forefront of Medicaid, Medicare, and the Health Insurance Marketplace for Centene.

Lannett officials said that the company received approval of its Abbreviated New Drug Application (ANDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, a generic version of Aggrenox® Capsules, 25 mg/200 mg (Boehringer Ingelheim Pharmaceuticals).

Novartis’ siponimod (Mayzent) is approved for adults with active secondary progressive multiple sclerosis, clinically isolated syndrome, and relapsing-remitting disease.

Program uses archived samples from patients with known treatment outcomes to accelerate research in predicting therapeutic responses for future patients with cancer.

Managed Health Care Associates’ Annual Business Summit covers wide range of topics, including insights on managing cost and improving operational efficiencies.

Top news of the day from across the health care industry.

Study finds chronic hepatitis C virus infection should not delay the initiation of an urgent cancer therapy.

Oklahoma Attorney General Mike Hunter filed a lawsuit against Purdue Pharma and 3 other manufacturers of opioid pain medications in 2017. In the filing on behalf of the state, he claimed these companies utilized deceptive marketing campaigns over the previous decade, which helped fuel the state’s opioid epidemic.

According to PQA, pharmacist-provided care can transform the pharmacist’s role in health care from a medication dispenser to an indispensable clinical care team member providing affordable, accessible and high-quality health care services that improve patient outcomes.

The program trains pharmacists in the many facets of association management, including executive leadership, strategic planning, member engagement, and more.

Preventive drugs are frequently continued in patients with cancer near end of life despite limited clinical benefit.

Study finds older patients administered combined immunosuppression experienced similar remission of Crohn disease as those aged under 60 years.

Top news of the day from across the health care industry.

Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.